128940.KS
Hanmi Pharm. Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 515,000.00
+2.59%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 440.7B
Latest reported
- Last report date
- Jul 28, 2026
- EPS actual
- KRW 6.5K
- EPS estimate
- KRW 4.1K
- Revenue actual
- KRW 467.2B
- Revenue estimate
- KRW 430.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +60.1%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 28, 2026 | KRW 4.1K | KRW 6.5K | Beat 60.09% | KRW 467.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026